Search Results

Business

Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods

Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods.

September 6, 2023

·

6 min read

Business

Oxford Nanopore and PathoQuest announce the first steps in a strategic collaboration to bring the first GMP-accredited, nanopore-based biologics genetic characterisation test to market

Oxford Nanopore Technologies plc and PathoQuest announce the agreement of a MOU for a collaboration to commercialise a transformational Integration Site Analysis test to better meet the evolving needs of the biopharmaceutical industry and the advancement of biological therapeutics.

March 21, 2023

·

4 min read

PathoQuest Receives GMP Certification for Its NGS-based Quality Control Testing Services of Biological Drugs

PathoQuest today announced that it has obtained a Good Manufacturing Practices (GMP) certificate for its quality control testing activities at its French-based facilities in Paris (France), following a recent inspection by the French National Agency for the Safety of Medicine and Health Products (ANSM).

November 24, 2021

·

3 min read

Business

Charles River and PathoQuest Strengthen Strategic Partnership

PathoQuest establishes U.S. subsidiary with state-of-the-art biologics genomic testing laboratory in Wayne, PA to expand its next-generation sequencing capabilities

November 12, 2020

·

4 min read

PathoQuest’s Paris-based Facility Obtains GLP Certificate for the Company’s Biologics Genomic Quality Control Testing Service

PathoQuest, a company with expertise in genomic analysis, announced today that it has received GLP certificate of conformity following a successful inspection by the French National Agency for Medicine and Health Products Safety (ANSM).

January 23, 2020

·

2 min read

Deals

PathoQuest Secures 8 Million Euros in New Financing

PathoQuest announces the closing of an 8M euros financing series.

September 5, 2019

·

5 min read

Business

Charles River Laboratories and PathoQuest Expand Strategic Biologics Partnership

Charles River will provide clients access to PathoQuest’s NGS-based testing solutions

April 9, 2018

·

5 min read

Business

PathoQuest Announces New Appointments to Executive Leadership Team

Company adds experienced executives to support the continued growth of Biologics Genomic Service and Clinical Diagnostics businesses which utilize PathoQuest’s proprietary Next-Generation Sequencing (NGS) based testing solution.

July 10, 2018

·

5 min read

Business

PathoQuest Names Dr. Christiane Honisch to Board of Directors

PathoQuest today announced the appointment of Christiane Honisch, Ph.D. as an independent member of the Company’s Board of Directors.

September 25, 2018

·

3 min read

Business

PathoQuest and Mayo Clinic Enter Into an Agreement to Conduct Study of iDTECT Blood in Patients With Febrile Neutropenia

PathoQuest announced that it will conduct research with Mayo Clinic to study the company’s proprietary iDTECT Blood test.

December 14, 2017

·

2 min read